首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   152020篇
  免费   14846篇
  国内免费   9005篇
耳鼻咽喉   1127篇
儿科学   1930篇
妇产科学   1659篇
基础医学   22002篇
口腔科学   2672篇
临床医学   18485篇
内科学   20753篇
皮肤病学   1649篇
神经病学   7128篇
特种医学   5131篇
外国民族医学   65篇
外科学   14099篇
综合类   25812篇
现状与发展   29篇
一般理论   12篇
预防医学   11464篇
眼科学   3583篇
药学   17710篇
  121篇
中国医学   8839篇
肿瘤学   11601篇
  2024年   583篇
  2023年   2286篇
  2022年   5912篇
  2021年   7528篇
  2020年   5544篇
  2019年   4880篇
  2018年   5118篇
  2017年   4821篇
  2016年   4552篇
  2015年   6710篇
  2014年   8369篇
  2013年   8268篇
  2012年   11714篇
  2011年   12385篇
  2010年   8884篇
  2009年   7123篇
  2008年   8472篇
  2007年   8353篇
  2006年   7498篇
  2005年   6695篇
  2004年   5160篇
  2003年   4949篇
  2002年   4191篇
  2001年   3494篇
  2000年   3001篇
  1999年   2626篇
  1998年   1660篇
  1997年   1785篇
  1996年   1252篇
  1995年   1192篇
  1994年   1090篇
  1993年   763篇
  1992年   967篇
  1991年   886篇
  1990年   791篇
  1989年   726篇
  1988年   651篇
  1987年   564篇
  1986年   528篇
  1985年   424篇
  1984年   369篇
  1983年   302篇
  1982年   268篇
  1981年   229篇
  1980年   196篇
  1979年   198篇
  1978年   192篇
  1977年   211篇
  1976年   191篇
  1974年   156篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
941.
Laboratory for the Search for and Study of Agents for Prevention and Treatment of Drug Addictions, Research Institute of Pharmacology, Academy of Medical Sciences of the USSR, Moscow. (Presented by Academician of the Academy of Medical Sciences of the USSR A. V. Val'dman.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 108, No. 12, pp. 700–702, December, 1989.  相似文献   
942.
Research Institute of General Pathology and Pathological Physiology, Academy of Medical Sciences of the USSR Research Laboratory of Biologically Active Substances of Hydrobionts, Ministry of Health of the USSR, Moscow. (Presented by Academician of the Academy of Medical Sciences of the USSR G. N. Kryzhanovskii.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 108, No. 8, pp. 139–142, August, 1989.  相似文献   
943.
为证实内皮细胞微丝与血管内皮完整性之间的直接关系,用Rhodamine-phalloidin显示了体外培养的牛主动脉内皮细胞形成一微密单层细胞后的微丝形态及用细胞毒素B孵育单层内皮细胞后的细胞形态及微丝的变化。结果表明:内皮细胞内的微丝结构DPB是维持内皮细胞之间连接的重要结构。文内还对内皮细胞微丝结构与动脉粥样硬化早期病变的关系进行了讨论。  相似文献   
944.
945.
In a previous study, we used transfectants expressing hybrid HLA-DR(beta 1*0403)/DR(beta 1*0701) chains to map sequences involved in polymorphic antibody binding epitopes on DR(alpha, beta 1*0403) or DR(alpha, beta 1*0701) molecules. Amino acids 1-40 of the beta 1 domain were found to make the major contributions to most of the antibody binding epitopes studied. To begin to localize sequences that contribute to polymorphic antibody epitopes on DR(alpha,beta 1*0101), DR(alpha,beta 1*1101) and DR(alpha,beta 3*0202) molecules, we used indirect immunofluorescence and flow cytometry to assess the binding of mAb to transfectants expressing hybrid DR(beta 1*0101)/DR(beta 1*1101) or DR(beta 1*1101)/DR(beta 3*0202) chains that divide the DR beta chain into three segments: amino acids 1-40, 41-97, and the beta 2 domain. The results indicate that amino acids 41-97 of the beta 1 domain on DR(beta 1*0101), DR(beta 1*1101), or DR(beta 3*0202) are critical in most of the epitopes, including those recognized by human antibodies MP4 and MP12, and mouse mAb GS88.2, I-LR1, 21r5, and 7.3.19.1, whereas amino acids 1-40 of DR(beta 1*1101) are critical in the epitope recognized by the MCS-7 mAb, and both segments 1-40 and 41-97 of DR(beta 1*1101) are important in the epitopes recognized by the I-LR2 and UL-52 mAbs. Based on these data and comparison of DR beta allelic protein sequences, the residues that may play critical roles in these antibody binding epitopes are predicted.  相似文献   
946.
947.
948.
Changes in HIV-1 incidence in heroin users in Guangxi Province, China   总被引:10,自引:0,他引:10  
Guangxi Province, China recently experienced an outbreak of HIV-1 infection among heroin users. We studied HIV-1 incidence rates and associated risk factors for HIV-1 infection among heroin users residing in Pingxiang City. A total of 318 heroin users were followed from February 1998 through January 1999 (median follow-up: 8.1 months). Of these, 130 were prospectively followed from January through September 1999 (median follow-up: 8.3 months). HIV-1 and hepatitis C virus (HCV) incidence rates for each period were calculated. A generalized estimating equation approach was implemented to identify independent risk factors associated with HIV-1 infection across both periods. Among 318 study participants, 97.2% were men. The median age was 22 years. Approximately 60% reported sharing needles. HIV-1 prevalence at baseline was 15.4%. During the first follow-up period, HIV-1 incidence was 2.38 per 100 person years (py), and HCV incidence was 26.8 per 100 py. During the second follow-up period, HIV-1 incidence was 6.86 per 100 py, and HCV incidence was 28.9 per 100 py. After controlling for age and other factors, HCV seropositivity, history of sexually transmitted diseases, and sharing needles were independently associated with HIV-1 infection. These data suggest that HIV-1 incidence was rising over time in Pingxiang City, Guangxi Province. The high incidence of HCV heightens the importance of enhanced prevention programs to reduce injection and needle sharing among heroin users.  相似文献   
949.
Department of Biomembranes, Research Center for Development and Introduction of Modern Methods of Molecular Diagnosis, Ministry of Health of the USSR, Moscow. (Presented by Academician of the Academy of Medical Sciences of the USSR I. P. Ashmarin.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 109, No. 5, pp. 483–485, May, 1990.  相似文献   
950.
Laboratory of Regulation of Immunopoiesis, Institute of Clinical Immunology, Siberian Branch, Academy of Medical Sciences of the USSR, Novosibirsk. (Presented by Academician of the Academy of Medical Sciences of the USSR V. P. Kaznacheev.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 105, No. 3, pp. 311–313, March, 1988.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号